Can-Fite BioPharma
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CANF and other ETFs, options, and stocks.About CANF
Can-Fite BioPharma Ltd. is a biopharmaceutical company, which engages in the development of drugs for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. Its product pipeline include Piclidenoson, Namodenoson, and CF602.
CEOMotti Farbstein
CEOMotti Farbstein
Employees5
Employees5
HeadquartersRamat Gan, HaMerkaz
HeadquartersRamat Gan, HaMerkaz
Founded1994
Founded1994
Employees5
Employees5
CANF Key Statistics
Market cap24.02M
Market cap24.02M
Price-Earnings ratio-0.17
Price-Earnings ratio-0.17
Dividend yield—
Dividend yield—
Average volume1.67M
Average volume1.67M
High today$0.35
High today$0.35
Low today$0.313
Low today$0.313
Open price$0.3332
Open price$0.3332
Volume900.32K
Volume900.32K
52 Week high$2.33
52 Week high$2.33
52 Week low$0.28
52 Week low$0.28
Stock Snapshot
The current Can-Fite BioPharma(CANF) stock price is $0.33, with a market capitalization of 24.02M. The stock trades at a price-to-earnings (P/E) ratio of -0.17.
On 2025-12-07, Can-Fite BioPharma(CANF) stock moved within a range of $0.31 to $0.35. With shares now at $0.33, the stock is trading +5.4% above its intraday low and -5.7% below the session's peak.
Trading activity shows a volume of 900.32K, compared to an average daily volume of 1.67M.
Over the past 52 weeks, Can-Fite BioPharma(CANF) stock has traded between a high of $2.33 and a low of $0.28.
Over the past 52 weeks, Can-Fite BioPharma(CANF) stock has traded between a high of $2.33 and a low of $0.28.